|
|
Post by mymann on Apr 26, 2023 23:33:24 GMT -5
We Longs were so happy few months ago with sp over 5 and dreaming about going up to 8 by end of year. Now the market is causing this down turn sp in 3's. Maybe the peds study is not doing well or Clofazimine study Mike was so excited about pooped out and needs more shares to keep getting paid until gets replaced. But it's another buying opportunity!
|
|
|
|
Post by sweedee79 on Apr 27, 2023 0:07:47 GMT -5
PC, it is appropriate.. I've been frustrated with this stock for years and yet I stayed here when there is so much more going on.. I don't believe in MC the way that you do, nor do many others..and that is OK.. so why do some here get so damn irate about others peoples opinions... I'm certainly not short!!!
I don't see Mikes path changing that much from what he has always done..people are tired of it.. I need an Elon kind of character to invest in ..someone taking risks and thinking outside of the box.. I'm thinking there will be all kinds of bargains coming soon.. this market is going lower IMO. People are going to get real scared and that's the best time to buy!!! If you believe in Mike buy more MNKD..
Al is who got me in this years ago and his out of the box thinking.. I believed in Afrezza so much.. but there were too many road blocks and that made this impossible.. the problems have never been and still aren't addressed.
I dont want to be on a large ship with a small rudder..or whatever you said... I DONT care about all of the excuses.. I DON'T care!! Just get the effing job done or my money can't afford to be here anymore when there are way way better places to be with better CEOs.. he isn't my buddy!! This isn't personal.
|
|
|
|
Post by sweedee79 on Apr 27, 2023 0:27:43 GMT -5
And PC.. there were a lot more problems than Sanofi..we were given a noninferior label.. the way the trials were set up wasn't good.. we needed a superior label.. the price point was way above all else... The PBMs were in our way.. etc etc. None of that has ever been addressed.. we just get more carrots dangled in front of us while MC gets a bigger bonus.. I'm not sure about our other pipeline opportunities or their promise.. all I can say is thank God for UTHR!!! Cuz that's what saved the day..
|
|
|
|
Post by mytakeonit on Apr 27, 2023 2:19:15 GMT -5
And do you think UTHR came on to save you ? The plan is in place ... you just have to wait for it. End of May is coming with the conference call ... patience is a virtue.
I definitely don't lose any sleep over this ...
Good luck to you and yours ...
But, that's mytakeonit
|
|
|
|
Post by sportsrancho on Apr 27, 2023 2:40:52 GMT -5
Major bargains coming soon…..
Agree, they’re calling for a hard landing ..seven months of a recession with a recovery early next year.
|
|
|
|
Post by sweedee79 on Apr 27, 2023 3:34:16 GMT -5
And do you think UTHR came on to save you ? The plan is in place ... you just have to wait for it. End of May is coming with the conference call ... patience is a virtue. I definitely don't lose any sleep over this ... Good luck to you and yours ... But, that's mytakeonit Save me? What are you talking about? I don't need saving.. I'm excited about the bargains coming!!!! I actually sold all MNKD weeks ago... I really wasn't holding much anymore anyway... Im in cash at the moment.. looking to reposition when the time is right. I'm not losing sleep over this.. I work overnights.. |
|
|
|
Post by letitride on Apr 27, 2023 4:57:06 GMT -5
As Afrezza finds its place in the standard of care a billion shares would not be to many in my mind. I see the potential here for Afrezza to find its place in front of the current insulin cartel. That it could actually become the SOC for most. The PEDS trial is in full swing, with a superior outcome Afrezza will become the beast unleashed in my opinion. I could go on and on about where we have been. But to me it is far more important where we are going and that the runway is clear to get there. I bought into Mannkind in 2013 and loaded heavily as MC turned it around in 2020. Would I like to see more hell yes. Am I willing to wait you bet.
|
|
|
|
Post by myocat on Apr 27, 2023 6:51:30 GMT -5
As Afrezza finds its place in the standard of care a billion shares would not be to many in my mind. I see the potential here for Afrezza to find its place in front of the current insulin cartel. That it could actually become the SOC for most. The PEDS trial is in full swing, with a superior outcome Afrezza will become the beast unleashed in my opinion. I could go on and on about where we have been. But to me it is far more important where we are going and that the runway is clear to get there. I bought into Mannkind in 2013 and loaded heavily as MC turned it around in 2020. Would I like to see more hell yes. Am I willing to wait you bet. I assume you made it good, as I did when I got all out last week. I was a loyal holder until the latest proxy came out. By the time the dilution approved, PPS will probably be around $2 and it could be in the $1.00. May be I will jump back in by then. Good luck to those who hold. |
|
|
|
Post by hellodolly on Apr 27, 2023 7:28:49 GMT -5
As Afrezza finds its place in the standard of care a billion shares would not be to many in my mind. I see the potential here for Afrezza to find its place in front of the current insulin cartel. That it could actually become the SOC for most. The PEDS trial is in full swing, with a superior outcome Afrezza will become the beast unleashed in my opinion. I could go on and on about where we have been. But to me it is far more important where we are going and that the runway is clear to get there. I bought into Mannkind in 2013 and loaded heavily as MC turned it around in 2020. Would I like to see more hell yes. Am I willing to wait you bet. I assume you made it good, as I did when I got all out last week. I was a loyal holder until the latest proxy came out. By the time the dilution approved, PPS will probably be around $2 and it could be in the $1.00. May be I will jump back in by then. Good luck to those who hold. Why do you confuse "authorization of more shares" with some immediate sense of automatic dilution? It could take years before they ever fully go through the shares they're requesting to be authorized and, if they don't have enough shares (as an example) to fulfill the compensation package, which is contractually legal and binding, MNKD could be entwined in years of litigation by their own employees. How would that look? These shares have a variety of uses, as spelled out in the prospectus that was delivered to everyone who gets a proxy. Does it mean the share price won't touch $2? No. But, does it also mean that it touched $2 because of the authorization for more shares? Again, no. The conflating of the two ideas is, in my own opinion, a mistake and can easily confuse the readers. Besides, every time a request for the authorization of more shares is announced, it is by far the easiest target for shorts to pound on, especially the unsophisticated. Speaking of, I read an opinion elsewhere in this thread that the share price may be dropping because of some concerns MC must be having because the Clofazimine study "pooped out" or peds study "not doing well"? I must say, we have a lot of wild speculation that makes reading these comments very entertaining and worthy of some engagement. Still, reminds me of Yahoo and StockTwits. As an investor in this space for decades and currently in ~30 biotechs and several medical hardware device companies, I can say with absolute certainty that the short brigade have never, ever found a better piece of propaganda than using the #1 favorite "fear of dilution", even if it never happens, with so much infatuation. In fact, come to think of it, every stock position I hold in and out of biotech in my portfolio, it's the same infatuation. |
|
|
|
Post by BD on Apr 27, 2023 7:38:53 GMT -5
TSLA was recently almost $400/share ... so now they are only about 40% of that. But every stock has its ups and downs. MNKD will have its time to shine very soon. But, that's mytakeonit TLSA's ATH was 333.33. And while it has its ups and downs, the periodicity is such that a long-term believer can make money within a reasonably small fraction of their lifetime. |
|
|
|
Post by mango on Apr 27, 2023 7:40:21 GMT -5
I voted "NO" to most of the proposals, except a yes to keep the accountant. I then dumped all of my fu&&cking holding and got the fu*)*ck out. After 8yrs....... Good luck to you all. Happy to hear you took action into your own hands and did the one thing that will relieve your misery. Good luck on your next venture! |
|
|
|
Post by sportsrancho on Apr 27, 2023 7:54:26 GMT -5
I assume you made it good, as I did when I got all out last week. I was a loyal holder until the latest proxy came out. By the time the dilution approved, PPS will probably be around $2 and it could be in the $1.00. May be I will jump back in by then. Good luck to those who hold. Why do you confuse "authorization of more shares" with some immediate sense of automatic dilution? It could take years before they ever fully go through the shares they're requesting to be authorized and, if they don't have enough shares (as an example) to fulfill the compensation package, which is contractually legal and binding, MNKD could be entwined in years of litigation by their own employees. How would that look? These shares have a variety of uses, as spelled out in the prospectus that was delivered to everyone who gets a proxy. Does it mean the share price won't touch $2? No. But, does it also mean that it touched $2 because of the authorization for more shares? Again, no. The conflating of the two ideas is, in my own opinion, a mistake and can easily confuse the readers. Besides, every time a request for the authorization of more shares is announced, it is by far the easiest target for shorts to pound on, especially the unsophisticated. Speaking of, I read an opinion elsewhere in this thread that the share price may be dropping because of some concerns MC must be having because the Clofazimine study "pooped out" or peds study "not doing well"? I must say, we have a lot of wild speculation that makes reading these comments very entertaining and worthy of some engagement. Still, reminds me of Yahoo and StockTwits. As an investor in this space for decades and currently in ~30 biotechs and several medical hardware device companies, I can say with absolute certainty that the short brigade have never, ever found a better piece of propaganda than using the #1 favorite "fear of dilution", even if it never happens, with so much infatuation. In fact, come to think of it, every stock position I hold in and out of biotech in my portfolio, it's the same infatuation. Because it’s just a well-known fact …what people should ask at the shareholder meeting is what are they going to be used for? |
|
|
|
Post by phdedieu12 on Apr 27, 2023 7:55:51 GMT -5
Here is where I should have put my money... TSLA(for example) 6-7-2019 - 13.63 1-7-2022 - 342.32 25Xs Yeah we have a run up occasionally.. but how long does it stay there? So after a decade I'm suppose to be happy with this? Some people here are taking this very personal.. sorry but I don't think Mike has done anything that great. Kathy Wood predicting 2k a share for TSLA in the long run.. I'm looking elsewhere ... Patients wearing thin and understandably so.. I am looking at the price over the last 5 years till present day, not cherry picking, period. If you're not happy with your return go get a better one. Where is TSLA now? Stop the ridiculous games, just be intellectually honest, stop comparing other stocks that moved better than MNKD, stop whining if you're not happy, sell your position and invest your money somewhere else. How quickly you forget that if not for Mike your position would be a big fat $0 right now, that is 100% loss. I don't know what your expectations were, and what return would make you happy, nor do I care, numbers are what they are, and I for one find it to be a healthy profit and while I wouldn't mind seeing $20, $6-7 by the end of the year, $8-10 next year is music to my ears |
|
|
|
Post by sportsrancho on Apr 27, 2023 8:02:02 GMT -5
STOP!
This is ridiculous ..number one, don’t tell people to sell their shares. That’s just a way to bully people into shutting up.
Number two: Her investment would’ve never gone zero because she wouldn’t have let it.
Number three, she’s already out!
|
|
|
|
Post by letitride on Apr 27, 2023 8:11:19 GMT -5
Should have, would have, could have. I am long Mannkind!
|
|
